feed,title,long_url,short_url
Benzinga,Johnson & Johnson's Cell Therapy Carvykti Shows Better Survival Rate In Pretreated Blood Cancer Patients,https://benzinga.com/general/biotech/24/07/39598597/johnson-johnsons-cell-therapy-carvykti-shows-better-survival-rate-in-pretreated-blood-cancer-pati,https://da.gd/rHVTX
